YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Advanced Melanoma
Related studies linked through entity extraction aliases.
A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- N/A
The Oncopanel Pilot (TOP) Study
- Status
- COMPLETED
- Phase
- N/A
PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase II FANG™ in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study of Tesetaxel in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.
- Status
- COMPLETED
- Phase
- PHASE1
Study of Temzolomide and Gleevec in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE1
Dendritic Cell Based Therapy of Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2